Akari Therapeutics, Plc
AKTX
$1.21
$0.1059.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.79M | -20.16M | -20.13M | -16.58M | -10.01M |
| Total Depreciation and Amortization | 14.00K | 14.00K | 15.00K | 16.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 686.00K | 117.00K | 601.00K | -332.00K | -5.56M |
| Change in Net Operating Assets | 6.54M | 5.19M | 3.72M | 1.30M | -866.00K |
| Cash from Operations | -12.55M | -14.84M | -15.80M | -15.60M | -16.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 382.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 382.00K | -- | -- | -- | -- |
| Total Debt Issued | 1.03M | 1.03M | 1.00M | 0.00 | 0.00 |
| Total Debt Repaid | -1.86M | -882.00K | -546.00K | -215.00K | -- |
| Issuance of Common Stock | 11.95M | 12.34M | 12.34M | 5.54M | 7.02M |
| Repurchase of Common Stock | -136.00K | -136.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.99M | 12.35M | 12.79M | 5.32M | 7.02M |
| Foreign Exchange rate Adjustments | -4.00K | 1.00K | -2.00K | 2.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.19M | -2.49M | -3.00M | -10.27M | -9.41M |